Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Lymphoma, Mantle-Cell × Carmustine × 90 days × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Lymphoma 2 Vasculitis, Central Nervous System 1 Stiff-Person Syndrome 1 Recurrence 1 Rasmussen subacute encephalitis 1 Polyradiculoneuropathy, Chronic Inflammatory Demyelinating 1 Pancreatic Neoplasms 1 Opsoclonus-Myoclonus Syndrome 1 Neuromyelitis Optica 1 Neoplasm Metastasis 1 Myasthenia Gravis 1 Lymphoma, T-Cell, Peripheral 1 Lymphoma, Mantle-Cell 1 Lymphoma, Large B-Cell, Diffuse 1 Lambert-Eaton Myasthenic Syndrome 1 Immunoblastic Lymphadenopathy 1 Enteropathy-Associated T-Cell Lymphoma 1 Breast Neoplasms 1 Autoimmune Diseases of the Nervous System 1 Autoimmune Diseases 1

Interventions

Rituximab 19 Cyclophosphamide 15 fludarabine 9 acalabrutinib 9 venetoclax 8 ibrutinib 8 zanubrutinib 7 pirtobrutinib 7 Magnetic Resonance Spectroscopy 7 CT-P10 7 obinutuzumab 6 glofitamab 6 fludarabine phosphate 6 Cytarabine 6 Specimen Handling 5 Lenalidomide 5 Bendamustine Hydrochloride 5 Vincristine 4 Doxorubicin 4 Biopsy 4 Whole-Body Irradiation 3 Prednisone 3 Mycophenolic Acid 3 Immunotherapy, Adoptive 3 Etoposide 3 Dexamethasone 3 Cyclosporine 3 brexucabtagene autoleucel 2 Therapeutics 2 Tacrolimus 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02896582 2026-01-14

LyMa101

The Lymphoma Academic Research Organisation

Phase 2 Completed

Lymphoma, Mantle-Cell

Data powered by HemOnc (CC BY 4.0) Colophon ⚡